Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

3 AC&R Study Summaries: Fractures in Patients with SSc, Clinical Response in JIA, & TV & the Public Perception of Gout

Arthritis Care & Research  |  Issue: August 2023  |  August 13, 2023

Main conclusions? Individual patients with pcJIA treated with SC or IV abatacept who achieved one of the end points generally maintained them over 21 months. Implications for patients? Patients aged 2–17 years old with pcJIA who achieve both a meaningful clinical and PRO response relatively early after starting SC or IV abatacept are likely to continue to have a good long-term response to the treatment.

Implications for clinicians? Clinicians can feel confident that overall and individual patients with pJIA treated with either SC or IV abatacept who achieve both a meaningful clinical and PRO end point simultaneously at four months will likely maintain long-term benefits.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The study: Brunner HI, Tzaribachev N, Louw I, et al. Long-term maintenance of clinical responses by individual patients with polyarticular-course juvenile idiopathic arthritis treated with abatacept. Arthritis Care Res (Hoboken). 2023 May 23.

TV & the Public Perception of Gout

By Rachel Murdoch, MBChB, Borislav Mihov, BPhty, Anne M. Horne, MBChB, Keith J. Petrie, PhD, Gregory D. Gamble, MSc, & Nicola Dalbeth, MD

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Why was this study done? Gout is frequently portrayed in the media as a humorous disease caused by overindulgence in food and alcohol. The impact of these depictions on public perceptions has not previously been explored.

Study methods? Two hundred members of the public were randomized to watch either a 19-minute commercial television comedy depicting gout as a humorous and embarrassing disease caused by a poor diet and managed through lifestyle changes, or a control episode from the same television series that did not mention gout. Participants completed a survey assessing illness perceptions and were asked about the likely causes and management strategies for gout.

Key findings? Participants who watched the gout episode were more likely to rate poor eating habits as the most important cause of gout than those viewing the control episode and were less likely to believe it was due to genetic factors or chance. They believed they had a greater understanding of gout and that the condition would have a greater effect on a person’s life. They also believed a change in diet would be a more effective management strategy than longterm medication use.

Main conclusions? Fictional depictions of gout have an important impact on perceptions of the public about the disease. Despite believing they had a greater understanding of gout, those who viewed the gout episode were less likely to believe long-term medication would be effective.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline ArthritisPatient PerspectivePractice ManagementResearch ReviewsResearch RheumSystemic Sclerosis Tagged with:juvenile idiopathic arthritis (JIA)polyarticular juvenile idiopathic arthritis (JIA)Reading Rheumsystemic sclerosis (SSc)

Related Articles

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Progress Continues in Systemic Sclerosis

    March 1, 2010

    Advances in genetics and potential therapies shed new light on the disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences